Login
$IRON
$76.59 +$0.00 (0.0%) After hours

$IRON SEC Filings

Filed On Filing
12 Nov 2026 Form 4: Savage William Jacob, Chief Medical Officer

Sold 16,035 shares ($1.36M)

10 Nov 2026 144
05 Nov 2026 424B5
05 Nov 2026 10-Q
05 Nov 2026 8-K: Results of Operations and Financial Condition

Pivotal Phase 3 APOLLO trial of bitopertin in erythropoietic protoporphyria (EPP) successfully met all primary and secondary endpoints

26 Oct 2026 SCHEDULE 13D/A
22 Oct 2026 8-K: Entry into a Material Definitive Agreement; Results of Operations and Financial Condition +1 more

Disc Medicine, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters named in Schedule I hereto (the “Underwriters”) 6,000,000 shares of its common stock, par value $0.0001 per share (the “F...

21 Oct 2026 Form 4: Bitterman Kevin, Director

Sold 10,994 shares ($879K) · Sold 5,312 shares ($425K) · Sold 25,519 shares ($2.05M)

21 Oct 2026 424B5
21 Oct 2026 144
21 Oct 2026 144
21 Oct 2026 144
21 Oct 2026 144
20 Oct 2026 144
20 Oct 2026 144
20 Oct 2026 144
20 Oct 2026 144
20 Oct 2026 424B5
19 Oct 2026 144
19 Oct 2026 144

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support